Comerica Bank Castle Biosciences Inc Transaction History
Comerica Bank
- $24.4 Billion
- Q4 2024
A detailed history of Comerica Bank transactions in Castle Biosciences Inc stock. As of the latest transaction made, Comerica Bank holds 207 shares of CSTL stock, worth $5,655. This represents 0.0% of its overall portfolio holdings.
Number of Shares
207Holding current value
$5,655% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding CSTL
# of Institutions
210Shares Held
27.3MCall Options Held
161KPut Options Held
38K-
Black Rock Inc. New York, NY3.04MShares$83.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$50.1 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.8MShares$49.1 Million0.24% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.44MShares$39.2 Million0.02% of portfolio
-
Dimensional Fund Advisors LP Austin, TX999KShares$27.3 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $718M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...